EUVIMEDEUVIMED entdecken
Crossref

METTL16-mediated m6A modification of LYRM2 drives breast cancer progression by inducing CD8+ T cell dysfunction via Glycolysis

Mao Li, Haipeng Shen, Tianya Zhang, Xin Jin, Gaopei Jin, Yihao Cai

Journal of Bioenergetics and Biomembranes · 2026-12 · 58 (1)

DOI: 10.1007/s10863-026-10100-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bioenergetics and Biomembranes, online erschienen am 18.03.2026. Verfasst von Mao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Thyroid and Breast Surgery, Zhuji People's Hospital, Zhuji, 311800, Zhejiang, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Breast Neoplasms, Glycolysis. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesBreast NeoplasmsGlycolysisHumansFemaleAnimalsMiceDisease Progression

Stichwörter der Autor:innen

Breast cancerCD8+ T cellsGlycolysisLYRM2METTL16

Autor:innen und Institutionen

  • Thyroid and Breast Surgery, Zhuji People's Hospital, Zhuji, 311800, Zhejiang, China.
  • Breast Surgery, Zhuji Maternity and Child Health Hospital, No.1 Yuxin Road, Jiyang Street, Zhuji, 311800, Zhejiang, China. zjyihaocai@163.com.

Zitieren

APA

Li, M., Shen, H., Zhang, T., Jin, X., Jin, G., & Cai, Y. (2026). METTL16-mediated m6A modification of LYRM2 drives breast cancer progression by inducing CD8+ T cell dysfunction via Glycolysis. Journal of Bioenergetics and Biomembranes, 58(1). https://doi.org/10.1007/s10863-026-10100-6

Vancouver

Li M, Shen H, Zhang T, Jin X, Jin G, Cai Y. METTL16-mediated m6A modification of LYRM2 drives breast cancer progression by inducing CD8+ T cell dysfunction via Glycolysis. Journal of Bioenergetics and Biomembranes. 2026;58(1). doi:10.1007/s10863-026-10100-6

BibTeX
@article{Li2026,
  author = {Li, Mao and Shen, Haipeng and Zhang, Tianya and Jin, Xin and Jin, Gaopei and Cai, Yihao},
  title = {METTL16-mediated m6A modification of LYRM2 drives breast cancer progression by inducing CD8+ T cell dysfunction via Glycolysis},
  journal = {Journal of Bioenergetics and Biomembranes},
  year = {2026},
  volume = {58},
  number = {1},
  doi = {10.1007/s10863-026-10100-6}
}
Kostenlos starten →